OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Hematology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	38
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	26
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	24
Deficits in our understanding of natural killer cell development in mouse and human	23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	21
Age-dependent regulation of hematopoiesis by megakaryocytes	21
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	20
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	20
Disparities in acute myeloid leukemia treatments and outcomes	18
Mesenchymal stromal cells: an update	18
Developmental regulation of primitive erythropoiesis	17
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives	16
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	16
The impact of obesity-induced inflammation on clonal hematopoiesis	15
Platelet lifespan and mechanisms for clearance	15
Unraveling lipid metabolism for acute myeloid leukemia therapy	14
Confronting high-complexity situations in myeloproliferative neoplasms: from treating young patients to TP53-mutated and ‘unclassifiable’ entities	14
Humanized murine models of platelet function	13
Navigating prognostic stratification and approach to TP53-mutated myeloid neoplasms	12
Multifaceted roles of CRISPR technology in blood cancer research	12
Advances on the genetic basis of red cell membrane disorders	11
High-throughput genotyping tools for red blood cell antigens	11
Messengers of coagulopathy: complement-carrying extracellular vesicles in SARS-CoV-2 infection	11
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	11
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	10

Editorial introduction	10
Cellular contributions to the pathogenesis of anti-platelet factor 4 disorders	9
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	9
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	9
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	9
Editorial introductions	8
YY1 in hematopoietic stem cells: epigenetic regulation, chromatin architecture, and aging	8
Understanding and targeting erythroid progenitor cells for effective cancer therapy	8
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	8
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	8
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	7
Editorial introductions	7
Protease-activated receptors in endothelial health and dysfunction	7
Current Opinion in Hematology	7
The immunology of PF4 polyanion interactions	7
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	7
Modelling arterial thrombus formation in vitro	7
Red blood cell changes due to cancer and cancer treatments: a narrative review	6
Platelet transfusion	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	6
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	6
Chediak-Higashi syndrome	6
Platelets and platelet–leukocyte interactions in infectious diseases	6
Membrane phospholipids in the regulation of tissue factor procoagulant function	6
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	6
Editorial introduction	6
The state of prediction models in hematologic disease: a worrisome assessment	6
The fulfilled promise and unmet potential of umbilical cord blood	6
Myeloproliferative neoplasms in the young: unique disease patterns and therapeutic strategies	5
Platelet mitochondria: the mighty few	5
Editorial introductions	5
Recent advances in factor XII structure and function	5
Switching and increasing prophylaxis regimen with a genetically recombinant fusion of coagulation factor IX and albumin in haemophilia B: a case report	5
Advances in the pathophysiology and treatment of anaemia in multiple myeloma	5
Red cell extracellular vesicles and coagulation activation pathways	5
Models to study myelodysplastic syndrome and acute myeloid leukaemia	5
No time to die? Intrinsic apoptosis signaling in hematopoietic stem and progenitor cells and therapeutic implications	5
Novel approaches to measure transfusion effectiveness	5
Editorial introduction	5
Macrocytic anemias	5
Editorial introduction	5
Immunomodulatory roles of red blood cells	5
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices	5
Donor selection in allogeneic stem cell transplantation	5
Epigenetics of hematopoietic stem cell aging	5
Proteomic perspectives on platelet reactivity: towards precision thrombosis research	5
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding	4
Scoring systems to predict thrombotic complications in solid tumor patients	4
Platelet Fc gamma RIIA: time to go beyond the unknown	4

BEACH domain-containing proteins: emerging roles in hematopoiesis and immune homeostasis	4
Age-related micro-environmental changes as drivers of clonal hematopoiesis	4
Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island	4
The impact of prenatal inflammation on hematopoietic development	4
Hematopoietic stem cell collection for sickle cell disease gene therapy	4
N6-methyladenosine in hematological malignancies: a concise review	4
Pediatric acute myeloid leukemia – novel approaches	4
Immunologic effects of red blood cell and platelet transfusions in neonates	3
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease	3
The role of stem cell transplantation in the modern management of multiple myeloma	3
Iron status of blood donors	3
Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease	3
Editorial introductions	3
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases	3
Advances in chimeric antigen receptor-T therapies to target tumor resistance in B-cell malignancies	3
Editorial Introductions	2
Factor XI as a therapeutic target in neuroinflammatory disease	2
New molecules in the therapy of chronic graft-versus-host disease	2
Histological differences among thrombi in thrombotic diseases	2
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets	2
Editorial introduction	2
Direct megakaryopoiesis	2
Editorial introductions	2
From bud to stem: dynamics of hematopoietic stem cells that drive homing and mobilization	2
Fibrin structure, viscoelasticity and lysis face the interplay of biorelevant polyions	2
Clinical applications of PET imaging for evaluating treatment-induced vascular toxicity in oncology	2
Editorial introduction	2
The interplay between physical and mental health and its impact on outcomes for hemopoietic stem cell transplant patients	2
Clonal hematopoiesis of indeterminate potential: recent developments and perspectives	2
Platelet lipidomics and de novo lipogenesis: impact on health and disease	2
The role of hematopoiesis in bone repair: an update	2